000 01202 a2200337 4500
005 20250513071746.0
264 0 _c19940309
008 199403s 0 0 eng d
022 _a0006-8993
024 7 _a10.1016/0006-8993(93)90341-j
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHarley, A
245 0 0 _aIron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease.
_h[electronic resource]
260 _bBrain research
_cNov 1993
300 _a349-53 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aElectron Transport
_xdrug effects
650 0 4 _aGlutathione
_xmetabolism
650 0 4 _aIron
_xpharmacology
650 0 4 _aMalondialdehyde
_xmetabolism
650 0 4 _aMitochondria
_xdrug effects
650 0 4 _aOxidation-Reduction
650 0 4 _aPC12 Cells
650 0 4 _aParkinson Disease
_xphysiopathology
650 0 4 _aSubstantia Nigra
_xdrug effects
700 1 _aCooper, J M
700 1 _aSchapira, A H
773 0 _tBrain research
_gvol. 627
_gno. 2
_gp. 349-53
856 4 0 _uhttps://doi.org/10.1016/0006-8993(93)90341-j
_zAvailable from publisher's website
999 _c8298259
_d8298259